Monoclonal antibody 667 recognizes the variable region A motif of the ecotropic retrovirus CasBrE envelope glycoprotein and inhibits Env binding to the viral receptor

Journal of Virology

Volumn 77, Issue 20, 2003, Pages 10984-10993

  Dreja, Hanna ^a   Gros, Laurent ^a   Villard, Sylvie ^b   Bachrach, Estanislao ^a,c   Oates, Anna ^a,d   Granier, Claude ^b   Chardes, Thierry ^b   Mani, Jean Claude ^b   Piechaczyk, Marc ^a   Pelegrin, Mireia ^a  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^b CNRS   (France)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ENVELOPE PROTEIN; GLYCOPROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 667; PROTEIN CASBRE; RECOMBINANT ANTIBODY; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; CELL CULTURE; CELL STRAIN COS7; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYBRIDOMA; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PURIFICATION; RECEPTOR BINDING; RETROVIRUS; THERMODYNAMICS;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN DISEASES; CLONING, MOLECULAR; EPITOPE MAPPING; HUMANS; HYBRIDOMAS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; RECEPTORS, VIRUS; RETROVIRIDAE; TUMOR CELLS, CULTURED; VIRAL ENVELOPE PROTEINS;

EID: 0141566316     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.20.10984-10993.2003     Document Type: Article

References (53)

1. Anderson, K. P., Y. S. Lie, M. A. Low, S. R. Williams, F. M. Wurm, and M. Dinowitz. 1991. Defective endogenous retrovirus-like sequences and particles of Chinese hamster ovary cells. Dev. Biol. Stand. 75:123-132.
2. Bachrach, E., M. Marin, M. Pelegrin, G. Karavanas, and M. Piechaczyk. 2000. Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein. J. Virol. 74:8480-8486.
3. Bartal, A. H., C. Feit, R. Erlandson, and Y. Hirshaut. 1982. The presence of viral particles in hybridoma clones secreting monoclonal antibodies, N. Engl. J. Med. 306:1423.
4. Battini, J.-L., O. Danos, and J. M. Heard. 1995. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J. Virol. 69:713-719.
5. Battini, J.-L., J. M. Heard, and O. Danos. 1992. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J. Virol. 66:1468-1475.
6. Burkhart, M. D., S. C. Kayman, Y. He, and A. Pinter. 2003. Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU. J. Virol. 77:3993-4003.
7. Chardes, T., S. Villard, G. Ferrières, M. Piechaczyk, M. Cerutti, G. Devauchelle, and B. Pau. 1999. Efficient amplification and direct sequencing of mouse variable regions from any immunoglobulin gene family. FEBS Lett. 452:386-394.
8. Chesebro, B., W. Britt, L. Evans, K. Wehrly, J. Nishio, and M. Cloyd. 1983. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus. Virology 127:134-148.
9. Cole, K. S., J. L. Rowles, B. A. Jagerski, M. Murphey-Corb, T. Unangst, J. E. Clements, J. Robinson, M. S. Wyand, R. C. Desrosiers, and R. C. Montelaro. 1997. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J. Virol. 71:5069-5079.
10. Cosset, F. L., Y. Takeuchi, J.-L. Battini, R. A. Weiss, and M. K. L. Collins. 1995. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:7430-7436.
11. Davey, R. A., Y. Zuo, and J. M. Cunningham. 1999. Identification of a receptor-binding pocket on the envelope protein of Friend murine leukemia virus. J. Virol. 73:3758-3763.
12. Denkers, E. Y., C. C. Badger, J. A. Ledbetter, and I. D. Bernstein. 1985. Influence of antibody isotype on passive serotherapy of lymphoma. J. Immunol. 135:2183-2186.
13. DesGroseillers, L., M. Barrette, and P. Jolicoeur. 1984. Physical mapping of the paralysis-inducing determinant of a wild mouse ecotropic neurotropic retrovirus. J. Virol. 52:356-363.
14. Dimmock, N. J. 1993. Neutralization of animal Viruses. Curr. Top. Microbiol. Immunol. 183:1-149.
15. Evans, L. H., R. P. Morrison, F. G. Malik, J. Portis, and W. J. Britt. 1990. A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J. Virol. 64:6176-6183.
16. Frank, K. 1992. Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 48:9217-9232.
17. Gardner, M. B., B. E. Henderson, J. E. Officer, R. W. Rongey, J. C. Parker, C. Oliver, J. D. Estes, and R. J. Huebner. 1973. A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J. Natl. Cancer Inst. 51:1243-1254.
18. Gerhard, W., K. Mozdzanowska, M. Furchner, G. Washko, and K. Maiese. 1997. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 159:95-103.
19. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
20. Heard, J. M., and O. Danos. 1991. An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J. Virol. 65:4026-4032.
21. Heusser, C. H., C. L. Anderson, and H. M. Grey. 1977. Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line. J. Exp. Med. 145:1316-1327.
22. Hunter, E. 1997. Viral entry and receptors, p. 71-120. In J. Coffin, S. Hughes, and H. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
23. Jespersen, T., M. Duch, M. L. Carrasco, S. Warming, and F. S. Pedersen. 1999. Expression of heterologous genes from an IRES translational cassette in replication competent murine leukemia virus vectors. Gene 239:227-235.
24. Johnson, G., and T. T. Wu. 2001. Kabat Database and its applications: future directions. Nucleic Acids Res. 29:205-206.
25. Kaminski, M. S., K. Kitamura, D. G. Maloney, M. J. Campbell, and R. Levy. 1986. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma: a study of hybridoma class switch variants. J. Immunol. 136:1123-1130.
26. Karavanas, G., M. Marin, B. Salmons, W. Gunzburg, and M. Piechaczyk. 1998. Cell targeting by murine retroviral vectors. Crit. Rev. Oncol.-Hematol. 28:7-30.
27. Karlsson, R., and A. Falt. 1997. Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. J. Immunol. Methods 200:121-133.
28. Kipps, T. J., P. Parham, J. Punt, and L. A. Herzenberg. 1985. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J. Exp. Med. 161:1-17.
29. Lavillette, D., M. Maurice, C. Roche, S. J. Russell, M. Sitbon, and F.-L. Cosset. 1998. A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes. J. Virol. 72:9955-9965.
30. Lovatt, A., J. Black, D. Galbraith, I. Doherty, M. W. Moran, A. J. Shepherd, A. Griffen, A. Bailey, N. Wilson, and K. T. Smith. 1999. High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods. J. Virol. Methods 82:185-200.
31. McAtee, F. J., and J. L. Portis. 1985. Monoclonal antibodies specific for wild mouse neurotropic retrovirus: detection of comparable levels of virus replication in mouse strains susceptible and resistant to paralytic disease. J. Virol. 56:1018-1022.
32. Molina, F., D. Laune, C. Gougat, B. Pau, and C. Granier. 1996. Improved performances of spot multiple peptide synthesis. Pept. Res. 9:151-155.
33. Neuberger, M. S., and K. Rajewsky. 1981. Activation of mouse complement by monoclonal mouse antibodies. Eur. J. Immunol. 11:1012-1016.
34. Noel, D., T. Bernardi, I. Navarro-Teulon, M. Marin, J. P. Martinetto, F. Ducancel, J. C. Mani, B. Pau, M. Piechaczyk, and M. Biard-Piechaczyk. 1996. Analysis of the individual contributions of immunoglobulin heavy and light chains to the binding of antigen using cell transfection and plasmon resonance analysis. J. Immunol. Methods 193:177-187.
35. Noël, D., J. E. Dazard, M. Pelegrin, C. Jacquet, and M. Piechaczyk. 2002. Skin as a potential organ for ectopic monoclonal antibody production. J. Investig. Dermatol. 118:288-294.
36. Noël, D., M. Pelegrin, F. Brockly, A. H. Lund, and M. Piechaczyk. 2000. Sustained systemic delivery of monoclonal antibodies by genetically modified skin fibroblasts. J. Investig. Dermatol. 115:740-745.
37. Noël, D., M. Pelegrin, S. Kramer, C. Jacquet, N. Skander, and M. Piechaezyk. 2002. High in vivo production of a model monoclonal antibody on adenoviral gene transfer. Hum. Gene Ther. 13:1483-1493.
38. Noel, D., M. Pelegrin, M. Marin, M. Biard-Piechaczyk, J. C. Ourlin, J. C. Mani, and M. Piechaczyk. 1997. In vitro and in vivo secretion of cloned antibodies by genetically modified myogenic cells. Hum. Gene Ther. 8:1219-1229.
39. Parren, P. W., J. P. Moore, D. R. Burton, and Q. J. Sattentau. 1999. The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. AIDS 13:S137-S162.
40. Pelegrin, M., M. Marin, D. Noël, M. Del Rio, R. Saller, J. Stange, S. Mitzner, W. H. Günzburg, and M. Piechaczyk. 1998. Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells. Gene Ther. 5:828-834.
41. Pelegrin, M., M. Marin, D. Noël, and M. Piechaczyk. 1998. Genetically engineered antibodies in gene transfer and gene therapy. Hum. Gene Ther. 9:2165-2175.
42. Pelegrin, M., M. Marin, A. Oates, D. Noel, R. Saller, B. Salmons, and M. Piechaczyk. 2000. Immunotherapy of a viral disease by in vivo production of therapeutic monoclonal antibodies. Hum. Gene Ther. 11:1407-1415.
43. Pelegrin, M., and M. Piechaczyk. Application of recombinant antibodies in gene transfer and gene therapy. In T. Kieber-Emmons and Z. Steplewski (ed.), Therapeutic antibody technology, in press. Marcel Dekker, Inc., New York, N.Y.
44. Piechaczyk, M., T. Chardes, M. C. Cot, B. Pau, and J. M. Bastide. 1985. Production and characterization of monoclonal antibodies against human thyroglobulin. Hybridoma 4:361-367.
45. Pincus, S. H., R. Cole, R. Ireland, F. McAtee, R. Fujisawa, and J. Portis. 1995. Protective efficacy of nonneutralizing monoclonal antibodies in acute infection with murine leukemia virus. J. Virol. 69:7152-7158.
46. Portis, J. L., S. Czub, C. F. Garon, and F. J. McAtee. 1990. Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus. J. Virol. 64:1648-1656.
47. Portis, J. L., S. Czub, S. Robertson, F. McAtee, and B. Chesebro. 1995. Characterization of a neurologic disease induced by a polytropic murine retrovirus: evidence for differential targeting of ecotropic and polytropic viruses in the brain. J. Virol. 69:8070-8075.
48. Rassart, E., L. Nelbach, and P. Jolicoeur. 1986. Cas-Br-E murine leukemia virus: sequencing of the paralytogenic region of its genome and derivation of specific probes to study its origin and the structure of its recombinant genomes in leukemic tissues. J. Virol. 60:910-919.
49. Rozman, C., R. Vdilella, and J. Vives. 1982. Viral particles in hybridoma clones secreting monoclonal antibodies. Lancet 2:445-446.
50. Sitbon, M., J. Nishio, K. Wehrly, D. Lodmell, and B. Chesebro. 1985. Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses. Virology 141:110-118.
51. Thornton, D. H., and R. A. Nicholas. 1984. The hazards of retroviruses associated with monoclonal antibody production. Dev. Biol. Stand, 57:9-12.
52. Unkeless, J. C., and H. N. Eisen. 1975. Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages. J. Exp. Med. 142:1520-1533.
53. Wilson, J. A., M. Hevey, R. Bakken, S. Guest, M. Bray, A. L. Schmaljohn, and M. K. Hart. 2000. Epitopes involved in antibody-mediated protection from Ebola virus. Science 287:1664-1666.